18-42 Year Old Healthy Vaccinia-naïve Subjects Clinical Trials

RESULTS
Found (1) clinical trials

A Randomized, Open-label Phase III Non-inferiority Trial to Compare Indicators of Efficacy for MVA-BN® Smallpox Vaccine to ACAM2000® in 18-42 Year Old Healthy Vaccinia-naïve Subjects

Phase 3